Tatsuya Atsumi
#163,407
Most Influential Person Now
Researcher
Tatsuya Atsumi's AcademicInfluence.com Rankings
Tatsuya Atsumicomputer-science Degrees
Computer Science
#9591
World Rank
#10067
Historical Rank
Machine Learning
#4243
World Rank
#4292
Historical Rank
Artificial Intelligence
#4593
World Rank
#4655
Historical Rank
Database
#6562
World Rank
#6797
Historical Rank
Download Badge
Computer Science
Tatsuya Atsumi's Degrees
- PhD Computer Science University of Tokyo
- Masters Computer Science University of Tokyo
- Bachelors Computer Science University of Tokyo
Similar Degrees You Can Earn
Why Is Tatsuya Atsumi Influential?
(Suggest an Edit or Addition)Tatsuya Atsumi's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) (2006) (4892)
- Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I. (2000) (306)
- The Role of the Tissue Factor Pathway in the Hypercoagulable State in Patients with the Antiphospholipid Syndrome (1998) (285)
- Efficacy of the antiphospholipid score for the diagnosis of antiphospholipid syndrome and its predictive value for thrombotic events. (2012) (226)
- 14th International Congress on Antiphospholipid Antibodies Task Force. Report on antiphospholipid syndrome laboratory diagnostics and trends. (2014) (224)
- Outcome of patients with anticardiolipin antibodies: a 10 year follow-up of 52 patients (1998) (214)
- Enhanced formation and disordered regulation of NETs in myeloperoxidase-ANCA-associated microscopic polyangiitis. (2014) (197)
- Circulating oxidized LDL forms complexes with beta2-glycoprotein I: implication as an atherogenic autoantigen. (2003) (192)
- Ixekizumab, an interleukin-17A antagonist in the treatment of ankylosing spondylitis or radiographic axial spondyloarthritis in patients previously untreated with biological disease-modifying anti-rheumatic drugs (COAST-V): 16 week results of a phase 3 randomised, double-blind, active-controlled and (2018) (168)
- Testing for Antiphospholipid antibodies with Solid Phase Assays: guidance from the SSC of the ISTH (2014) (165)
- A specific ligand for beta(2)-glycoprotein I mediates autoantibody-dependent uptake of oxidized low density lipoprotein by macrophages. (2001) (140)
- The phenotype of infiltrating macrophages influences arteriosclerotic plaque vulnerability in the carotid artery. (2013) (139)
- Incidence and Risk Factors for Serious Infection in Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor Inhibitors: A Report from the Registry of Japanese Rheumatoid Arthritis Patients for Longterm Safety (2011) (134)
- Human beta 2-glycoprotein I binds to endothelial cells through a cluster of lysine residues that are critical for anionic phospholipid binding and offers epitopes for anti-beta 2-glycoprotein I antibodies. (1998) (123)
- ‘Non-criteria’ aPL tests: report of a task force and preconference workshop at the 13th International Congress on Antiphospholipid Antibodies, Galveston, TX, USA, April 2010 (2011) (113)
- The p38 mitogen-activated protein kinase (MAPK) pathway mediates induction of the tissue factor gene in monocytes stimulated with human monoclonal anti-β2Glycoprotein I antibodies (2004) (112)
- A Genome-Wide Association Study Identified AFF1 as a Susceptibility Locus for Systemic Lupus Eyrthematosus in Japanese (2012) (112)
- Clinical characteristics of cytomegalovirus infection in rheumatic diseases: multicentre survey in a large patient population. (2008) (110)
- Antiprothrombin antibodies detected in two different assay systems (2005) (110)
- The efficacy of tacrolimus in patients with interstitial lung diseases complicated with polymyositis or dermatomyositis. (2015) (110)
- The responses of macrophages in interaction with neutrophils that undergo NETosis. (2016) (108)
- Ixekizumab for patients with non-radiographic axial spondyloarthritis (COAST-X): a randomised, placebo-controlled trial (2019) (103)
- Autoantibodies to human prothrombin and clinical manifestations in 207 patients with systemic lupus erythematosus. (1998) (98)
- Novel Assays of Thrombogenic Pathogenicity in the Antiphospholipid Syndrome Based on the Detection of Molecular Oxidative Modification of the Major Autoantigen β2-Glycoprotein I (2011) (97)
- The association of a nonsynonymous single-nucleotide polymorphism in TNFAIP3 with systemic lupus erythematosus and rheumatoid arthritis in the Japanese population. (2010) (96)
- The first double-blind, randomised, parallel-group certolizumab pegol study in methotrexate-naive early rheumatoid arthritis patients with poor prognostic factors, C-OPERA, shows inhibition of radiographic progression (2015) (92)
- Japan College of Rheumatology 2009 guidelines for the use of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, in rheumatoid arthritis (2009) (88)
- Brief Report: Takayasu Arteritis and Ulcerative Colitis: High Rate of Co‐Occurrence and Genetic Overlap (2015) (88)
- Comparison of adding tocilizumab to methotrexate with switching to tocilizumab in patients with rheumatoid arthritis with inadequate response to methotrexate: 52-week results from a prospective, randomised, controlled study (SURPRISE study) (2016) (88)
- Elevated plasma lipoprotein(a) level and its association with impaired fibrinolysis in patients with antiphospholipid syndrome. (1998) (87)
- Continuation of Methotrexate Resulted in Better Clinical and Radiographic Outcomes Than Discontinuation upon Starting Etanercept in Patients with Rheumatoid Arthritis: 52-week Results from the JESMR Study (2011) (85)
- Peptidylarginine Deiminase Inhibitor Suppresses Neutrophil Extracellular Trap Formation and MPO-ANCA Production (2016) (81)
- Arterial disease in lupus and secondary antiphospholipid syndrome: association with anti-beta2-glycoprotein I antibodies but not with antibodies against oxidized low-density lipoprotein. (1998) (80)
- A chimeric antibody with the human γ1 constant region as a putative standard for assays to detect IgG β2‐glycoprotein I–dependent anticardiolipin and anti–β2‐glycoprotein I antibodies (1999) (80)
- Etanercept (ETN) with methotrexate (MTX) is better than ETN monotherapy in patients with active rheumatoid arthritis despite MTX therapy: a randomized trial (2010) (77)
- The coagulation/fibrinolysis balance in systemic sclerosis: evidence for a haematological stress syndrome. (1997) (75)
- Antiphospholipid antibodies increase the risk of pregnancy-induced hypertension and adverse pregnancy outcomes. (2009) (74)
- Severity-based treatment for Japanese patients with MPO-ANCA-associated vasculitis: the JMAAV study (2011) (73)
- Amelioration of fatty liver index in patients with type 2 diabetes on ipragliflozin: an association with glucose-lowering effects. (2017) (72)
- Autoantibodies against oxidized low-density lipoprotein in antiphospholipid syndrome. (1997) (72)
- Defective Expression of Ras Guanyl Nucleotide-Releasing Protein 1 in a Subset of Patients with Systemic Lupus Erythematosus1 (2007) (68)
- Transethnic meta-analysis identifies GSDMA and PRDM1 as susceptibility genes to systemic sclerosis (2017) (68)
- Antiphospholipid antibody associated thrombocytopenia and the paradoxical risk of thrombosis (2005) (68)
- Time‐dependent increased risk for serious infection from continuous use of tumor necrosis factor antagonists over three years in patients with rheumatoid arthritis (2012) (66)
- Anti‐β2‐glycoprotein I antibodies in children with atopic dermatitis (2002) (65)
- Correlation between β2-glycoprotein I valine/leucine247 polymorphism and anti-β2-glycoprotein I antibodies in patients with primary antiphospholipid syndrome (1999) (62)
- Measurement of NET formation in vitro and in vivo by flow cytometry (2017) (62)
- Cigarette Smoking, Alcohol Consumption, and Risk of Systemic Lupus Erythematosus: A Case-control Study in a Japanese Population (2012) (60)
- Change of synovial vascularity in a single finger joint assessed by power doppler sonography correlated with radiographic change in rheumatoid arthritis: Comparative study of a novel quantitative score with a semiquantitative score (2010) (60)
- Nicked beta2-glycoprotein I: a marker of cerebral infarct and a novel role in the negative feedback pathway of extrinsic fibrinolysis. (2004) (59)
- Specificities, properties, and clinical significance of antiprothrombin antibodies. (2003) (59)
- The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort. (2019) (57)
- Antiphospholipid antibodies: lessons from the bench. (2007) (57)
- Significance of valine/leucine247 polymorphism of beta2-glycoprotein I in antiphospholipid syndrome: increased reactivity of anti-beta2-glycoprotein I autoantibodies to the valine247 beta2-glycoprotein I variant. (2005) (56)
- Metformin prevents liver tumorigenesis induced by high-fat diet in C57Bl/6 mice. (2013) (55)
- Autoantibodies to IgG/HLA class II complexes are associated with rheumatoid arthritis susceptibility (2014) (54)
- Long-term efficacy and safety of tocilizumab in refractory Takayasu arteritis: final results of the randomized controlled phase 3 TAKT study (2020) (54)
- Radiographic prognosis of finger joint damage predicted by early alteration in synovial vascularity in patients with rheumatoid arthritis: Potential utility of power doppler sonography in clinical practice (2011) (52)
- Autoimmune disease after autologous hematopoietic stem cell transplantation. (2008) (51)
- HLA class II gene polymorphisms in antiphospholipid syndrome: haplotype analysis in 83 Caucasoid patients. (2001) (51)
- Butyrate suppresses tumor necrosis factor alpha production by regulating specific messenger RNA degradation mediated through a cis-acting AU-rich element. (2005) (50)
- Drug retention rates and relevant risk factors for drug discontinuation due to adverse events in rheumatoid arthritis patients receiving anticytokine therapy with different target molecules (2012) (50)
- The p38 mitogen-activated protein kinase (MAPK) pathway mediates induction of the tissue factor gene in monocytes stimulated with human monoclonal anti-beta2Glycoprotein I antibodies. (2004) (49)
- A chimeric antibody with the human gamma1 constant region as a putative standard for assays to detect IgG beta2-glycoprotein I-dependent anticardiolipin and anti-beta2-glycoprotein I antibodies. (1999) (48)
- Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trial (2020) (48)
- Hepatitis B Virus Reactivation by Immunosuppressive Therapy in Patients with Autoimmune Diseases: Risk Analysis in Hepatitis B Surface Antigen-negative Cases (2011) (48)
- Filgotinib in combination with methotrexate or as monotherapy versus methotrexate monotherapy in patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: the phase 3, randomised controlled FINCH 3 trial (2021) (48)
- Pathophysiology of thrombosis and pregnancy morbidity in the antiphospholipid syndrome (2012) (48)
- Multiple autoimmune diseases after autologous stem-cell transplantation. (2007) (47)
- β2-Glycoprotein I/HLA class II complexes are novel autoantigens in antiphospholipid syndrome. (2015) (47)
- Regulatory polymorphisms in EGR2 are associated with susceptibility to systemic lupus erythematosus. (2010) (46)
- Factor XI is a substrate for oxidoreductases: enhanced activation of reduced FXI and its role in antiphospholipid syndrome thrombosis. (2012) (46)
- Suppressed intrinsic fibrinolytic activity by monoclonal anti‐beta‐2 glycoprotein I autoantibodies: possible mechanism for thrombosis in patients with antiphospholipid syndrome (2002) (46)
- Ipragliflozin effectively reduced visceral fat in Japanese patients with type 2 diabetes under adequate diet therapy. (2016) (45)
- Genetic determinants and an epistasis of LILRA3 and HLA-B*52 in Takayasu arteritis (2018) (45)
- Complement and thrombosis in the antiphospholipid syndrome. (2016) (45)
- Evaluation of phosphatidylserine-dependent antiprothrombin antibody testing for the diagnosis of antiphospholipid syndrome: results of an international multicentre study (2017) (45)
- Coagulation and fibrinolytic activities in 2 siblings with beta(2)-glycoprotein I deficiency. (2000) (43)
- The efficacy of calcineurin inhibitors for the treatment of interstitial lung disease associated with polymyositis/dermatomyositis (2015) (42)
- Autoantibodies against malondialdehyde-modified lipoprotein(a) in antiphospholipid syndrome. (1999) (42)
- Understanding the Antibody Repertoire in Neuropsychiatric Systemic Lupus Erythematosus and Neuromyelitis Optica Spectrum Disorder (2018) (42)
- Monitoring anti-interleukin 6 receptor antibody treatment for rheumatoid arthritis by quantitative magnetic resonance imaging of the hand and power Doppler ultrasonography of the finger (2011) (41)
- Long-term outcome in Japanese patients with lupus nephritis (2014) (41)
- Thrombotic risk stratification by platelet count in patients with antiphospholipid antibodies: a longitudinal study (2017) (40)
- Transcriptional regulator Bhlhe40 works as a cofactor of T-bet in the regulation of IFN-γ production in iNKT cells (2016) (40)
- First‐Line, Non‐Criterial Antiphospholipid Antibody Testing for the Diagnosis of Antiphospholipid Syndrome in Clinical Practice: A Combination of Anti–β2‐Glycoprotein I Domain I and Anti–Phosphatidylserine/Prothrombin Complex Antibodies Tests (2018) (40)
- A Comparison of the Effects of the GLP-1 Analogue Liraglutide and Insulin Glargine on Endothelial Function and Metabolic Parameters: A Randomized, Controlled Trial Sapporo Athero-Incretin Study 2 (SAIS2) (2015) (40)
- Antiprothrombin antibody: why do we need more assays? (2010) (40)
- Up-Regulated Tissue Factor Expression in Antiphospholipid Syndrome (1997) (39)
- Antiprothrombin antibodies--are they worth assaying? (2004) (39)
- Splicing variant of WDFY4 augments MDA5 signalling and the risk of clinically amyopathic dermatomyositis (2018) (39)
- Risk modification by CYP1A1 and GSTM1 polymorphisms in the association of cigarette smoking and systemic lupus erythematosus in a Japanese population (2012) (38)
- Antiprothrombin antibody testing: detection and clinical utility. (2008) (38)
- Cigarette Smoking, STAT4 and TNFRSF1B Polymorphisms, and Systemic Lupus Erythematosus in a Japanese Population (2009) (38)
- Primary prophylaxis to prevent obstetric complications in asymptomatic women with antiphospholipid antibodies: a systematic review (2015) (38)
- Pathogenesis of antiphospholipid antibodies: impairment of fibrinolysis and monocyte activation via the p38 mitogen-activated protein kinase pathway. (2005) (37)
- Circulating Neutrophil Extracellular Trap Levels in Well-Controlled Type 2 Diabetes and Pathway Involved in Their Formation Induced by High-Dose Glucose (2016) (36)
- β2-glycoprotein I, anti-β2-glycoprotein I, and fibrinolysis (2004) (36)
- Up-regulated expression of HLA-DRB5 transcripts and high frequency of the HLA-DRB5*01:05 allele in scleroderma patients with interstitial lung disease. (2012) (35)
- Sonographic synovial vascularity of synovitis in rheumatoid arthritis. (2014) (35)
- Vertebral fracture and bone mineral density in women receiving high dose glucocorticoids for treatment of autoimmune diseases. (2005) (35)
- An independent validation of the Global Anti-Phospholipid Syndrome Score in a Japanese cohort of patients with autoimmune diseases (2015) (35)
- Comparison of severity classification in Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis in a nationwide, prospective, inception cohort study (2016) (34)
- Prothrombin Mutation Is not Associated with Thrombosis in Patients with Antiphospholipid Syndrome (1998) (34)
- The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody–Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository (2019) (34)
- The effects of phosphatidylserine-dependent antiprothrombin antibody on thrombin generation. (2009) (34)
- A randomized controlled trial comparing the effects of dapagliflozin and DPP-4 inhibitors on glucose variability and metabolic parameters in patients with type 2 diabetes mellitus on insulin (2017) (33)
- Antiprothombin antibodies and the diagnosis of antiphospholipid syndrome. (2004) (33)
- Antiphospholipid antibodies in leprotic patients: a correlation with disease manifestations. (2000) (31)
- Gain-of-function polymorphism in mouse and human Ltk: implications for the pathogenesis of systemic lupus erythematosus. (2003) (31)
- Anti-beta(2)-glycoprotein I antibodies in children with atopic dermatitis. (2002) (31)
- Diagnostic value of antiagalactosyl IgG antibodies in rheumatoid arthritis (2004) (30)
- Research around β2-glycoprotein I: A major target for antiphospholipid antibodies (2005) (30)
- A Randomized Controlled Trial Comparing the Effects of Sitagliptin and Glimepiride on Endothelial Function and Metabolic Parameters: Sapporo Athero-Incretin Study 1 (SAIS1) (2016) (29)
- Immunological Reconstitution after Autologous Hematopoietic Stem Cell Transplantation in Patients with Systemic Sclerosis: Relationship Between Clinical Benefits and Intensity of Immunosuppression (2009) (29)
- The role of antirheumatics in patients with COVID-19 (2021) (29)
- Antigenic structures recognized by anti-beta2-glycoprotein I auto-antibodies. (2005) (29)
- The short-term role of corticosteroid therapy for pulmonary arterial hypertension associated with connective tissue diseases: report of five cases and a literature review (2011) (29)
- Efficacy and safety of baricitinib in Japanese patients with rheumatoid arthritis: Subgroup analyses of four multinational phase 3 randomized trials (2018) (29)
- Safety and effectiveness of 24-week treatment with iguratimod, a new oral disease-modifying antirheumatic drug, for patients with rheumatoid arthritis: interim analysis of a post-marketing surveillance study of 2679 patients in Japan (2017) (29)
- COVID-19 pandemic in Japan (2020) (28)
- Incidence and risk factors for reactivation from resolved hepatitis B virus in rheumatoid arthritis patients treated with biological disease‐modifying antirheumatic drugs (2018) (28)
- Gene polymorphisms of tissue plasminogen activator and plasminogen activator inhibitor-1 in patients with antiphospholipid antibodies. (2002) (28)
- Sustainable Efficacy of Switching From Intravenous to Subcutaneous Tocilizumab Monotherapy in Patients With Rheumatoid Arthritis (2015) (28)
- Safety and effectiveness of iguratimod in patients with rheumatoid arthritis: Final report of a 52-week, multicenter postmarketing surveillance study (2019) (27)
- Fcγ Receptor IIA H/R131 Polymorphism in Patients with Antiphospholipid Antibodies (1998) (27)
- 2-glycoprotein Ianti-2-glycoprotein I Interaction (2000) (27)
- Overexpression of TNF-α converting enzyme promotes adipose tissue inflammation and fibrosis induced by high fat diet. (2014) (27)
- Decreased expression of Runx1 and lowered proportion of Foxp3+ CD25+ CD4+ regulatory T cells in systemic sclerosis (2015) (26)
- Factors associated with first thrombosis in patients presenting with obstetric antiphospholipid syndrome (APS) in the APS Alliance for Clinical Trials and International Networking Clinical Database and Repository: a retrospective study (2018) (26)
- Clinical benefit of 1-year certolizumab pegol (CZP) add-on therapy to methotrexate treatment in patients with early rheumatoid arthritis was observed following CZP discontinuation: 2-year results of the C-OPERA study, a phase III randomised trial (2017) (26)
- Effectiveness and safety of tocilizumab in achieving clinical and functional remission, and sustaining efficacy in biologics-naive patients with rheumatoid arthritis: The FIRST Bio study (2017) (26)
- Hyponatremia can be a powerful predictor of the development of isolated ACTH deficiency associated with nivolumab treatment [Letter to the Editor]. (2017) (26)
- Positive synovial vascularity in patients with low disease activity indicates smouldering inflammation leading to joint damage in rheumatoid arthritis: time-integrated joint inflammation estimated by synovial vascularity in each finger joint. (2013) (26)
- Genetics of antiphospholipid syndrome. (2001) (25)
- Nicked {beta}2-glycoprotein I binds angiostatin 4.5 (plasminogen kringle 1-5) and attenuates its antiangiogenic property. (2009) (25)
- Clinical features of reversible posterior leukoencephalopathy syndrome in patients with systemic lupus erythematosus (2011) (25)
- Differentiating biosimilarity and comparability in biotherapeutics (2016) (25)
- The p38 mitogen-activated protein kinase (MAPK) pathway mediates induction of the tissue factor gene in monocytes stimulated with human monoclonal anti- b 2 Glycoprotein I antibodies (2004) (25)
- Low levels of plasma protein S, protein C and coagulation factor XII during early pregnancy and adverse pregnancy outcome (2015) (25)
- Effect of the sodium–glucose cotransporter 2 inhibitor luseogliflozin on pancreatic beta cell mass in db/db mice of different ages (2018) (24)
- Parkinson-Like Symptoms as a Manifestation of Systemic Lupus Erythematosus (1993) (24)
- Serum adiponectin and insulin secretion: A direct or inverse association? (2018) (24)
- LAMP3 induces apoptosis and autoantigen release in Sjögren’s syndrome patients (2020) (24)
- Post-steroid neuropsychiatric manifestations are significantly more frequent in SLE compared with other systemic autoimmune diseases and predict better prognosis compared with de novo neuropsychiatric SLE. (2016) (24)
- LB0003 EFFICACY AND SAFETY OF FILGOTINIB FOR PATIENTS WITH RHEUMATOID ARTHRITIS NAïVE TO METHOTREXATE THERAPY: FINCH3 PRIMARY OUTCOME RESULTS (2019) (23)
- Essential role of the p38 mitogen-activated protein kinase pathway in tissue factor gene expression mediated by the phosphatidylserine-dependent antiprothrombin antibody. (2013) (23)
- Development of systemic lupus erythematosus after chemotherapy and radiotherapy for malignant thymoma. (1995) (23)
- Degludec is superior to glargine in terms of daily glycemic variability in people with type 1 diabetes mellitus. (2016) (23)
- Improvement in treatment satisfaction after switching from liraglutide to dulaglutide in patients with type 2 diabetes: A randomized controlled trial (2018) (23)
- Systemic lupus erythematosus: nothing stale her infinite variety (2018) (23)
- Impact of adding tacrolimus to initial treatment of interstitial pneumonitis in polymyositis/dermatomyositis: a single-arm clinical trial (2019) (22)
- Thrombomodulin as a Physiological Modulator of Intravascular Injury (2020) (22)
- Plasma gelsolin facilitates interaction between β2 glycoprotein I and α5β1 integrin (2009) (22)
- Pulmonary arterial hypertension associated with connective tissue diseases: A review focusing on distinctive clinical aspects (2018) (22)
- Significance of fully automated tests for the diagnosis of antiphospholipid syndrome. (2016) (21)
- Characteristics of Antiphospholipid Antibody Positive Patients in AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking. (2020) (21)
- The effects of vildagliptin compared with metformin on vascular endothelial function and metabolic parameters: a randomized, controlled trial (Sapporo Athero-Incretin Study 3) (2017) (21)
- Autophagy promotes citrullination of VIM (vimentin) and its interaction with major histocompatibility complex class II in synovial fibroblasts (2020) (20)
- Modifying Effect of N‐Acetyltransferase 2 Genotype on the Association Between Systemic Lupus Erythematosus and Consumption of Alcohol and Caffeine‐Rich Beverages (2014) (20)
- Prevalence of diverse antiphospholipid antibodies in women with recurrent spontaneous abortion. (2003) (20)
- The REAL database reveals no significant risk of serious infection during treatment with a methotrexate dose of more than 8 mg/week in patients with rheumatoid arthritis (2011) (20)
- Ovarian morphology and prevalence of polycystic ovary syndrome in Japanese women with type 1 diabetes mellitus (2013) (20)
- Pilot study of short-term effects of a novel long-acting oral beraprost in patients with pulmonary arterial hypertension. (2007) (20)
- A woman with infectious endocarditis caused by Abiotrophia defectiva. (2004) (19)
- The Presence of Anti-Lactoferrin Antibodies in a Subgroup of Eosinophilic Granulomatosis with Polyangiitis Patients and Their Possible Contribution to Enhancement of Neutrophil Extracellular Trap Formation (2016) (19)
- Anti-beta2 glycoprotein-I antibody increases the risk of pregnancy-induced hypertension: a case-controlled study. (2010) (19)
- Effects of dapagliflozin and/or insulin glargine on beta cell mass and hepatic steatosis in db/db mice. (2019) (19)
- A case of Crow-Fukase syndrome with elevated soluble interleukin-6 receptor in cerebrospinal fluid. Response to double-filtration plasmapheresis and corticosteroids. (1995) (19)
- How to Identify High-Risk APS Patients: Clinical Utility and Predictive Values of Validated Scores (2017) (19)
- Tissue factor in antiphospholipid syndrome: shifting the focus from coagulation to endothelium. (2003) (19)
- Satisfaction of switching to combination therapy with lixisenatide and basal insulin in patients with type 2 diabetes receiving multiple daily insulin injection therapy: A randomized controlled trial (2017) (19)
- Formation and Disordered Degradation of Neutrophil Extracellular Traps in Necrotizing Lesions of Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis. (2019) (19)
- Evaluation of the alternative classification criteria of systemic lupus erythematosus established by Systemic Lupus International Collaborating Clinics (SLICC) (2018) (19)
- Increased Expression of Phospholipid Scramblase 1 in Monocytes from Patients with Systemic Lupus Erythematosus (2010) (18)
- Antiphospholipid syndrome, “the best prophet of the future” (2018) (18)
- Ras Guanine Nucleotide–Releasing Protein 4 Is Aberrantly Expressed in the Fibroblast‐like Synoviocytes of Patients With Rheumatoid Arthritis and Controls Their Proliferation (2015) (18)
- [Systemic lupus erythematosus associated with benign intracranial hypertension: a case report]. (1992) (18)
- Long-term safety and efficacy of rituximab in 7 Japanese patients with ANCA-associated vasculitis (2015) (18)
- Autoantibodies against a complement component 1 q subcomponent contribute to complement activation and recurrent thrombosis/pregnancy morbidity in anti-phospholipid syndrome. (2016) (18)
- Clinical relevance of antiprothrombin antibodies. (2002) (18)
- Myeloperoxidase/HLA Class II Complexes Recognized by Autoantibodies in Microscopic Polyangiitis (2017) (17)
- Decreased Expression of Serine/Arginine‐Rich Splicing Factor 1 in T Cells From Patients With Active Systemic Lupus Erythematosus Accounts for Reduced Expression of RasGRP1 and DNA Methyltransferase 1 (2018) (17)
- Contrast-enhanced whole-body joint MRI in patients with unclassified arthritis who develop early rheumatoid arthritis within 2 years: feasibility study and correlation with MRI findings of the hands. (2010) (17)
- Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION Registry (2020) (17)
- Branched-chain amino acids enhance cyst development in autosomal dominant polycystic kidney disease. (2017) (17)
- OP0040 Adding Tocilizumab or Switching to Tocilizumab Monotherapy in RA Patients with Inadequate Response to Methotrexate: 24-Week Results from a Randomized Controlled Study (Surprise Study) (2013) (17)
- Safety and tolerability of sifalimumab, an anti-interferon-α monoclonal antibody, in Japanese patients with systemic lupus erythematosus: A multicenter, phase 2, open-label study (2020) (17)
- MicroRNA-9 ameliorates destructive arthritis through down-regulation of NF-κB1-RANKL pathway in fibroblast-like synoviocytes. (2020) (17)
- Elevation of KL-6 serum levels in clinical trials of tumor necrosis factor inhibitors in patients with rheumatoid arthritis: a report from the Japan College of Rheumatology Ad Hoc Committee for Safety of Biological DMARDs (2013) (17)
- Severe hepatic involvement without inflammatory changes in systemic lupus erythematosus: report of two cases and review of the literature (1995) (17)
- [Parkinsonism-dementia complex]. (1977) (16)
- Antiphospholipid score is a novel risk factor for idiopathic osteonecrosis of the femoral head in patients with systemic lupus erythematosus (2018) (16)
- Glucokinase Inactivation Paradoxically Ameliorates Glucose Intolerance by Increasing β-Cell Mass in db/db Mice (2021) (16)
- Association Between Reappearance of Myeloperoxidase–Antineutrophil Cytoplasmic Antibody and Relapse in Antineutrophil Cytoplasmic Antibody–Associated Vasculitis (2018) (16)
- Analysis of bone metabolism during early stage and clinical benefits of early intervention with alendronate in patients with systemic rheumatic diseases treated with high-dose glucocorticoid: Early DIagnosis and Treatment of OsteopoRosis in Japan (EDITOR-J) study (2016) (16)
- Ectopic RASGRP2 (CalDAG-GEFI) expression in rheumatoid synovium contributes to the development of destructive arthritis (2018) (16)
- Circulating plasmablasts contribute to antiphospholipid antibody production, associated with type I interferon upregulation (2019) (16)
- The first genome-wide association study identifying new susceptibility loci for obstetric antiphospholipid syndrome (2017) (16)
- Anti‐Phosphatidylserine/Prothrombin Antibodies are not Frequently Found in Patients with Unexplained Recurrent Miscarriages (2001) (16)
- Pregnancy outcomes in women with rheumatic diseases: a real-world observational study in Japan (2019) (16)
- Overexpression of TNF-α-converting enzyme in fibroblasts augments dermal fibrosis after inflammation (2013) (16)
- Interferon-inducible Mx1 protein is highly expressed in renal tissues from treatment-naïve lupus nephritis, but not in those under immunosuppressive treatment (2018) (15)
- IgG2 restriction of anti-beta2-glycoprotein I as the basis for the association between IgG2 anticardiolipin antibodies and thrombosis in the antiphospholipid syndrome: comment on the article by Sammaritano et al. (1998) (15)
- The role of genetics and epigenetics in rheumatic diseases: are they really a target to be aimed at? (2018) (15)
- Efficacy of dual antiplatelet therapy for preventing recurrence of arterial thrombosis in patients with antiphospholipid syndrome. (2018) (15)
- Pre-conception status, obstetric outcome and use of medications during pregnancy of systemic lupus erythematosus (SLE), rheumatoid arthritis (RA) and inflammatory bowel disease (IBD) in Japan: Multi-center retrospective descriptive study (2020) (15)
- Autologous haematopoietic stem cell transplantation for Japanese patients with systemic sclerosis: Long-term follow-up on a phase II trial and treatment-related fatal cardiomyopathy (2018) (15)
- Relationship Between Visceral Fat and Plasma Aldosterone Concentration in Patients With Primary Aldosteronism (2018) (15)
- Reduction in glucose fluctuations in elderly patients with type 2 diabetes using repaglinide: A randomized controlled trial of repaglinide vs sulfonylurea (2018) (15)
- Impact of Weekly Teriparatide on the Bone and Mineral Metabolism in Hemodialysis Patients With Relatively Low Serum Parathyroid Hormone: A Pilot Study (2020) (15)
- Favorable effect of sodium–glucose cotransporter 2 inhibitor, dapagliflozin, on non‐alcoholic fatty liver disease compared with pioglitazone (2020) (14)
- Structural deterioration of finger joints with ultrasonographic synovitis in rheumatoid arthritis patients with clinical low disease activity. (2014) (14)
- Safety and effectiveness of subcutaneous tocilizumab in patients with rheumatoid arthritis in a real-world clinical setting (2018) (14)
- [Clinical significance of antiphospholipid antibodies]. (1998) (14)
- The comparison of real world and core laboratory antiphospholipid antibody ELISA results from antiphospholipid syndrome alliance for clinical trials & international networking (APS ACTION) clinical database and repository analysis. (2019) (14)
- 3 cases of anti-Scl-70 (topoisomerase I) antibody associated with central nervous system lupus without renal disorder. (1993) (14)
- Clinical features and pregnancy outcome in antiphospholipid syndrome patients with history of severe pregnancy complications (2015) (14)
- Beta2-glycoprotein I, anti-beta2-glycoprotein I, and fibrinolysis. (2004) (13)
- Polymyalgia rheumatica as the manifestation of unclassified aortitis (2008) (13)
- Successful management of a patient with active Cushing's disease complicated with coronavirus disease 2019 (COVID-19) pneumonia. (2020) (13)
- Increase in plasma thrombin-activatable fibrinolysis inhibitor may not contribute to thrombotic tendency in antiphospholipid syndrome because of inhibitory potential of antiphospholipid antibodies toward TAFI activation (2010) (13)
- Most anticardiolipin antibodies in mixed connective tissue disease are beta2-glycoprotein independent. (1998) (13)
- Treatment Patterns, Direct Cost of Biologics, and Direct Medical Costs for Rheumatoid Arthritis Patients: A Real-world Analysis of Nationwide Japanese Claims Data. (2016) (12)
- Thrombotic microangiopathy due to multiple autoantibodies related to antiphospholipid syndrome (2012) (12)
- Phosphatidylserine-dependent antiprothrombin antibodies are not useful markers for high-risk women with recurrent miscarriages. (2004) (12)
- Comparative effects of vildagliptin and sitagliptin determined by continuous glucose monitoring in patients with type 2 diabetes mellitus. (2016) (12)
- Pathophysiology of thrombosis and potential targeted therapies in antiphospholipid syndrome. (2011) (12)
- First external validation of sensitivity and specificity of the European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) classification criteria for idiopathic inflammatory myopathies with a Japanese cohort (2019) (12)
- Prediction of Response to Treatment by Gene Expression Profiling of Peripheral Blood in Patients with Microscopic Polyangiitis (2013) (12)
- The role of glucokinase and insulin receptor substrate-2 in the proliferation of pancreatic beta cells induced by short-term high-fat diet feeding in mice. (2018) (12)
- Pathogenic roles of anti-C1q antibodies in recurrent pregnancy loss. (2019) (12)
- Inhibition of Small Maf Function in Pancreatic β-Cells Improves Glucose Tolerance Through the Enhancement of Insulin Gene Transcription and Insulin Secretion. (2015) (12)
- Epalrestat Improves Diabetic Wound Healing via Increased Expression of Nerve Growth Factor (2013) (11)
- Impact of Glucose Loading on Variations in CD4+ and CD8+ T Cells in Japanese Participants with or without Type 2 Diabetes (2018) (11)
- Nivolumab-induced hypophysitis causing secondary adrenal insufficiency after transient ACTH elevation. (2019) (11)
- Phospholipid scramblase 1 expression is enhanced in patients with antiphospholipid syndrome (2013) (11)
- Convolutional neural network for classification of two-dimensional array images generated from clinical information may support diagnosis of rheumatoid arthritis (2020) (11)
- Increased urinary exosomal SYT17 levels in chronic active antibody-mediated rejection after kidney transplantation via the IL-6 amplifier. (2020) (11)
- Aberrant splicing of the hRasGRP4 transcript and decreased levels of this signaling protein in the peripheral blood mononuclear cells in a subset of patients with rheumatoid arthritis (2011) (11)
- β2-glycoprotein I and Anti-β2-glycoprotein I Antibodies (2006) (11)
- Favourable effect of the sodium‐glucose co‐transporter‐2 inhibitor canagliflozin plus the dipeptidyl peptidase‐4 inhibitor teneligliptin in combination on glycaemic fluctuation: An open‐label, prospective, randomized, parallel‐group comparison trial (the CALMER study) (2019) (11)
- Effect of switching from pioglitazone to the sodium glucose co‐transporter‐2 inhibitor dapagliflozin on body weight and metabolism‐related factors in patients with type 2 diabetes mellitus: An open‐label, prospective, randomized, parallel‐group comparison trial (2018) (11)
- Clinical significance of plasma presepsin levels in patients with systemic lupus erythematosus (2018) (11)
- Usefulness of the octreotide test in Japanese patients for predicting the presence/absence of somatostatin receptor 2 expression in insulinomas. (2016) (10)
- Surveillance for the use of mycophenolate mofetil for adult patients with lupus nephritis in Japan (2015) (10)
- LAMP3 inhibits autophagy and contributes to cell death by lysosomal membrane permeabilization (2021) (10)
- Lysosome-associated membrane protein 3 misexpression in salivary glands induces a Sjögren’s syndrome-like phenotype in mice (2021) (10)
- Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial (2019) (10)
- Advances in antiphospholipid (Hughes') syndrome. (1998) (10)
- Determination of clinically significant tests for antiphospholipid antibodies and cutoff levels for obstetric antiphospholipid syndrome (2015) (10)
- A retrospective study of serum KL-6 levels during treatment with biological disease-modifying antirheumatic drugs in rheumatoid arthritis patients: a report from the Ad Hoc Committee for Safety of Biological DMARDs of the Japan College of Rheumatology (2013) (10)
- Beta 2-glycoprotein I-anti-beta 2-glycoprotein I interaction. (2000) (10)
- The presence of anti-neutrophil extracellular trap antibody in patients with microscopic polyangiitis. (2019) (10)
- Case of fulminant type 1 diabetes induced by the anti‐programmed death‐ligand 1 antibody, avelumab (2019) (9)
- Decreased haptoglobin levels inversely correlated with pulmonary artery pressure in patients with pulmonary arterial hypertension (2017) (9)
- Immunology of anti-phospholipid antibodies and cofactors (2004) (9)
- Myofascia-dominant involvement on whole-body MRI as a risk factor for rapidly progressive interstitial lung disease in dermatomyositis. (2020) (9)
- Relationships between plasma lactate, plasma alanine, genetic variations in lactate transporters and type 2 diabetes in the Japanese population. (2019) (9)
- Regulatory polymorphisms in EGR 2 are associated with susceptibility to systemic lupus erythematosus (2010) (9)
- Morbidity and mortality in antiphospholipid syndrome based on cluster analysis: a 10-year longitudinal cohort study. (2020) (9)
- Overexpression of perilipin1 protects against atheroma progression in apolipoprotein E knockout mice. (2018) (9)
- Switching to Once-Daily Insulin Degludec/Insulin Aspart from Basal Insulin Improves Postprandial Glycemia in Patients with Type 2 Diabetes Mellitus: Randomized Controlled Trial (2019) (9)
- Antiphospholipid Antibody Profile Stability Over Time: Prospective Results From the APS ACTION Clinical Database and Repository (2020) (9)
- Effect of combined treatment with bisphosphonate and vitamin D on atherosclerosis in patients with systemic lupus erythematosus: a propensity score-based analysis (2018) (8)
- Bi-ventricular interplay in patients with systemic sclerosis-associated pulmonary arterial hypertension: Detection by cardiac magnetic resonance (2017) (8)
- Treatment-related damage in elderly-onset ANCA-associated vasculitis: safety outcome analysis of two nationwide prospective cohort studies (2020) (8)
- Clinical profiles and risk assessment in patients with antiphospholipid antibodies (2018) (8)
- [A case of an old woman with Sjögren's syndrome associated with insulin-dependent diabetes mellitus]. (1996) (8)
- Recombinant thrombomodulin ameliorates autoimmune vasculitis via immune response regulation and tissue injury protection. (2019) (8)
- Role of apolipoprotein B100 and oxidized low-density lipoprotein in the monocyte tissue factor induction mediated by anti-β2 glycoprotein I antibodies (2016) (8)
- Effects of 50 mg vildagliptin twice daily vs. 50 mg sitagliptin once daily on blood glucose fluctuations evaluated by long-term self-monitoring of blood glucose. (2017) (8)
- Maintenance treatment using abatacept with dose reduction after achievement of low disease activity in patients with rheumatoid arthritis (MATADOR) – A prospective, multicenter, single arm pilot clinical trial (2017) (7)
- Impaired insulin secretion predicting unstable glycemic variability and time below range in type 2 diabetes patients regardless of glycated hemoglobin or diabetes treatment (2020) (7)
- Expression and regulation of neuromedin B in pituitary corticotrophs of male melanocortin 2 receptor-deficient mice. (2014) (7)
- The Pathogenicity of BPI-ANCA in a Patient With Systemic Vasculitis (2019) (7)
- Circulating oxidized LDL forms complexes with β2-glycoprotein I Published, JLR Papers in Press, January 16, 2003. DOI 10.1194/jlr.M200329-JLR200 (2003) (7)
- [Pneumoperitoneum without perforation of the gastrointestinal tract in a patient with systemic lupus erythematosus]. (1991) (7)
- AB0431 Post-marketing surveillance of tofacitinib in japanese patients with rheumatoid arthritis: an interim report of safety data (2017) (7)
- A merged presentation of clinical and radiographic data using probability plots in a clinical trial, the JESMR study (2012) (7)
- AAA-ATPase p97 suppresses apoptotic and autophagy-associated cell death in rheumatoid arthritis synovial fibroblasts (2016) (7)
- Anti-cyclic citrullinated peptide antibody titers decrease in rheumatoid arthritis patients treated with tocilizumab: A pilot study (2020) (7)
- Treatment of Vasodilator-resistant Mixed Connective Tissue Disease-associated Pulmonary Arterial Hypertension with Glucocorticoid and Cyclophosphamide (2017) (7)
- Comparison of real world and core laboratory lupus anticoagulant results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) clinical database and repository (2019) (7)
- Effectiveness of whole-body magnetic resonance imaging for the efficacy of biologic anti-rheumatic drugs in patients with rheumatoid arthritis: A retrospective pilot study (2017) (7)
- Comparative analysis of different enzyme immunoassays for assessment of phosphatidylserine-dependent antiprothrombin antibodies (2014) (7)
- A case report dysregulated neutrophil extracellular traps in a patient with propylthiouracil-induced anti-neutrophil cytoplasmic antibody-associated vasculitis (2019) (7)
- Sodium–glucose cotransporter 2 inhibitors reduce day‐to‐day glucose variability in patients with type 1 diabetes (2020) (6)
- Accurate quantitative assessment of synovitis in rheumatoid arthritis using pixel-by-pixel, time-intensity curve shape analysis. (2016) (6)
- Should sulfonylurea be discontinued or maintained at the lowest dose when starting ipragliflozin? A multicenter observational study in Japanese patients with type 2 diabetes (2018) (6)
- [Tumor necrosis factor alpha in systemic lupus erythematosus: evaluation by restriction fragment length polymorphism and production by peripheral blood mononuclear cells]. (1992) (6)
- Proinsulin is sensitive to reflect glucose intolerance (2019) (6)
- Intravenous immunoglobulin therapy for aspirin-heparinoid-resistant antiphospholipid syndrome (2010) (6)
- SAT0257 Clinical and Radiographic Effects after 52-Week of Adding Tocilizumab or Switching to Tocilizumab in RA Patients with Inadequate Response to Methotrexate: Results from A Prospective Randomized Controlled Study (Surprise Study) (2014) (6)
- Flow cytometric identification and cell-line establishment of macrophages in naked mole-rats (2019) (6)
- Combination of alcohol and glucose consumption as a risk to induce reactive hypoglycemia (2020) (6)
- Prodromal signs and symptoms of serious infections with tocilizumab treatment for rheumatoid arthritis: Text mining of the Japanese postmarketing adverse event-reporting database (2018) (6)
- Tocilizumab reduced production of systemic sclerosis-related autoantibodies and anti-cyclic citrullinated protein antibodies in two patients with overlapping systemic sclerosis and rheumatoid arthritis (2018) (6)
- [A case of systemic lupus erythematosus (SLE) developing pan-dysautonomia]. (1992) (6)
- [Phosphatidylserine-dependent anti-prothrombin antibody as a new marker for the diagnosis of antiphospholipid syndrome]. (2006) (6)
- Lysosomal exocytosis of HSP70 stimulates monocytic BMP6 expression in Sjögren’s syndrome (2022) (6)
- Power Doppler signal calibration in the finger joint between two models of ultrasound machine: a pilot study using a phantom and joints in patients with rheumatoid arthritis (2017) (6)
- "Resurrection of thrombin" in the pathophysiology of the antiphospholipid syndrome. (2007) (6)
- The Fifth Domain of Beta 2 Glycoprotein I Protects from Natural IgM Mediated Cardiac Ischaemia Reperfusion Injury (2016) (6)
- Low C4 as a risk factor for severe neuropsychiatric flare in patients with systemic lupus erythematosus (2020) (6)
- Risk factors for development of systemic lupus erythematosus among Japanese females: medical history and reproductive factors (2017) (6)
- Satisfaction and efficacy of switching from daily dipeptidyl peptidase-4 inhibitors to weekly trelagliptin in patients with type 2 diabetes-Randomized controlled study. (2017) (6)
- A national survey on current use of mycophenolate mofetil for childhood-onset systemic lupus erythematosus in Japan (2015) (6)
- Protective Role of Optineurin Against Joint Destruction in Rheumatoid Arthritis Synovial Fibroblasts (2020) (6)
- Histopathological classification of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis in a nationwide Japanese prospective 2-year follow-up cohort study (2018) (6)
- Insulin-Induced Distant Site Lipoatrophy (2017) (6)
- A comparative study of PF‐06438179/GP1111 (an infliximab biosimilar) and reference infliximab in patients with moderate to severe active rheumatoid arthritis: A subgroup analysis (2020) (5)
- Log-linear relationship between endogenous insulin secretion and glycemic variability in patients with type 2 diabetes on continuous glucose monitoring (2021) (5)
- Clinical feature and anti-phospholipid antibody profiles of pregnancy failure in young women with antiphospholipid antibody syndrome treated with conventional therapy (2018) (5)
- Clinical significance of anti-beta 2-glycoprotein I antibodies. (1996) (5)
- Switching from Insulin Degludec plus Dipeptidyl Peptidase-4 Inhibitor to Insulin Degludec/Liraglutide Improves Glycemic Variability in Patients with Type 2 Diabetes: A Preliminary Prospective Observation Study (2022) (5)
- Alternative pathway activation due to low level of complement factor H in primary antiphospholipid syndrome. (2018) (5)
- Multiple thromboses in major arteries in a patient with antiphospholipid syndrome associated with excess of a large multimer of von Willebrand factor (2001) (5)
- Reactivation of occult hepatitis B virus infection in patients with rheumatic diseases: pathogenesis, risk assessment and prevention (2016) (5)
- Efficacy and safety of sodium RISedronate for glucocorticoid-induced OsTeoporosis with rheumaTOid arthritis (RISOTTO study): A multicentre, double-blind, randomized, placebo-controlled trial (2020) (5)
- AMPK Is Involved in the Regulation of Incretin Receptors Expression in Pancreatic Islets under a Low Glucose Concentration (2013) (5)
- Characteristics of Patients With Antiphospholipid Antibody Positivity in the APS ACTION International Clinical Database and Repository (2022) (5)
- Successful treatment of tocilizumab-resistant large vessel pulmonary arteritis with infliximab (2018) (5)
- Right ventricular dimension index by cardiac magnetic resonance for prognostication in connective tissue diseases and pulmonary hypertension. (2019) (5)
- Reduced diffusing capacity for carbon monoxide predicts borderline pulmonary arterial pressure in patients with systemic sclerosis (2019) (5)
- Clinical and Prognostic Significance of Non-criteria Antiphospholipid Antibody Tests (2017) (5)
- Clinical impact of urinary CD11b and CD163 on the renal outcomes of anti-neutrophil cytoplasmic antibody-associated glomerulonephritis. (2020) (5)
- A case of osteomalacia due to deranged mineral balance caused by saccharated ferric oxide and short-bowel syndrome (2017) (5)
- Factors with remission of fatty liver in patients with type 2 diabetes treated with ipragliflozin. (2019) (5)
- Composite assessment of power Doppler ultrasonography and MRI in rheumatoid arthritis: a pilot study of predictive value in radiographic progression after one year. (2018) (5)
- Uveitis, pancarditis, haemophagocytosis, and abdominal masses (2003) (5)
- Diagnostic and prognostic markers and treatment of connective tissue disease-associated pulmonary arterial hypertension: current recommendations and recent advances (2020) (5)
- [A case of rheumatoid arthritis developing pemphigus-like skin lesion during treatment with bucillamine]. (1991) (4)
- Projectile haemorrhage of a brachial artery in a patient with clinically amyopathic dermatomyositis. (2015) (4)
- Disease activity as a risk factor for venous thromboembolism in rheumatoid arthritis analysed using time-averaged DAS28CRP: a nested case–control study (2022) (4)
- Glucokinase activation leads to an unsustained hypoglycaemic effect with hepatic triglyceride accumulation in db/db mice (2021) (4)
- Clinical significance of anti‐DNA/N‐methyl‐D‐aspartate receptor 2 antibodies in de novo and post‐steroid cases with neuropsychiatric systemic lupus erythematosus (2018) (4)
- Prognosis and progress in immunotherapies for organ involvements in systemic autoimmune diseases. (2016) (4)
- Favorable effects of burosumab on tumor-induced osteomalacia caused by an undetectable tumor (2021) (4)
- Incidence and risk of antiresorptive agent-related osteonecrosis of the jaw (ARONJ) after tooth extraction in patients with autoimmune disease (2020) (4)
- Pregnancy outcomes in antiphospholipid antibody positive patients: prospective results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (‘Registry’) (2022) (4)
- Efficacy and safety of filgotinib in Japanese patients with refractory rheumatoid arthritis: Subgroup analyses of a global Phase 3 study (FINCH 2). (2020) (4)
- How should rheumatologists manage glucocorticoid-induced hyperglycemia? (2020) (4)
- A case of catastrophic antiphospholipid antibody syndrome complicated with systemic lupus erythematosus, double positive for anti-cardiolipin/β2 glycoprotein I and anti-phosphatidylserine/prothrombin autoantibodies (2012) (4)
- Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION): 10-Year Update (2021) (4)
- Upadacitinib monotherapy versus methotrexate monotherapy in methotrexate-naïve Japanese patients with rheumatoid arthritis: a sub-analysis of the Phase 3 SELECT-EARLY study (2020) (4)
- Real-world practice of obstetricians in respect of assays for antiphospholipid antibodies (2015) (4)
- Glucose tolerance is improved following surgery for silent somatotroph adenoma (2015) (4)
- A retrospective study of serum KL-6 levels during treatment with biological disease-modifying antirheumatic drugs in rheumatoid arthritis patients: a report from the Ad Hoc Committee for Safety of Biological DMARDs of the Japan College of Rheumatology (2013) (4)
- Effects of Switching from Liraglutide or Dulaglutide to Subcutaneous Semaglutide on Glucose Metabolism and Treatment Satisfaction in Patients with Type 2 Diabetes: Protocol for a Multicenter, Prospective, Randomized, Open-Label, Blinded-Endpoint, Parallel-Group Comparison Study (The SWITCH-SEMA 1 St (2021) (4)
- ' Non-criteria ' aPL tests : report of a task force and preconference workshop at the 13 th International (2011) (4)
- Non-tuberculosis Mycobacterium Tenosynovitis with Rice Bodies in a Patient with Systemic Lupus Erythematosus (2020) (4)
- Lowering of blood pressure and pulse rate by switching from DPP-4 inhibitor to luseogliflozin in patients with type 2 diabetes complicated with hypertension: a multicenter, prospective, randomized, open-label, parallel-group comparison trial (LUNA study). (2021) (3)
- Improved time in range and postprandial hyperglycemia with canagliflozin in combination with teneligliptin: Secondary analyses of the CALMER study (2021) (3)
- The development of quality indicators for systemic lupus erythematosus using electronic health data: A modified RAND appropriateness method (2020) (3)
- Antiphospholipid Syndrome and Atherosclerosis (2001) (3)
- Coronary and Mesenteric Involvement in Polyarteritis Nodosa (2015) (3)
- O127. Low levels of plasma protein S, protein C and coagulation factor XII during early pregnancy and adverse pregnancy outcome (2015) (3)
- Case with long-standing gout showing various ultrasonographic features caused by monosodium urate monohydrate crystal deposition (2020) (3)
- Glucokinase is required for high‐starch diet‐induced β‐cell mass expansion in mice (2021) (3)
- The association between hypoglycemia and glycemic variability in elderly patients with type 2 diabetes: a prospective observational study (2021) (3)
- Diagnosis of Antiphospholipid syndrome (2008) (3)
- Update on the Efficacy and Safety Profile of Voclosporin: An Integrated Analysis of Clinical Trials in Lupus Nephritis. (2022) (3)
- Complement profile in microscopic polyangiitis and granulomatosis with polyangiitis: analysis using sera from a nationwide prospective cohort study (2020) (3)
- [Thermography of collagen diseases with Raynaud's phenomenon]. (1991) (3)
- Diversity of borderline pulmonary arterial pressure associated with systemic sclerosis: 3 case series (2017) (3)
- Contrast-enhanced whole body joint MR imaging in rheumatoid patients on tumour necrosis factor-alpha agents: a pilot study to evaluate novel scoring system for MR synovitis. (2013) (3)
- Predictive value of serum amyloid a levels for requirement of concomitant methotrexate in tocilizumab initiation: A post hoc analysis of the SURPRISE study (2020) (3)
- Markers of thrombotic events in autoimmune diseases: Comparison of Antiphospholipid Score (aPL-S) and Global Anti-phospholipid Syndrome Score (GAPSS) (2015) (3)
- Exploratory classification of clinical phenotypes in Japanese patients with antineutrophil cytoplasmic antibody-associated vasculitis using cluster analysis (2021) (3)
- [Antiphospholipid antibody associated thrombocytopenia]. (2003) (3)
- Clinical significance of anti-β2-glycoprotein I antibodies (1996) (3)
- Psychological stress in a Japanese population with systemic lupus erythematosus: Finding from KYSS study (2014) (3)
- Detection of Increased Vascular Signal in Arthritis-Prone Rats Without Joint Swelling Using Superb Microvascular Imaging Ultrasonography. (2019) (3)
- Sjögren's syndrome-associated SNPs increase GTF2I expression in salivary gland cells to enhance inflammation development. (2021) (3)
- [Evaluation of F1 + 2/TAT ratios in Japanese patients with antiphospholipid syndrome]. (2000) (3)
- A polymorphism in human platelet antigen 6b and risk of thrombocytopenia in patients with systemic lupus erythematosus. (2007) (3)
- Calcineurin inhibitors for adult-onset Still's disease: a multicentre retrospective cohort study. (2020) (3)
- Breakdown of Autonomously Functioning Thyroid Nodule Accompanied by Acromegaly After Octreotide Treatment (2019) (3)
- Subcutaneous panniculitis-like T-cell lymphoma with haemophagocytic syndrome during tocilizumab therapy for juvenile idiopathic arthritis. (2017) (2)
- Anti- b 2 -glycoprotein I antibodies in children with atopic dermatitis (2)
- Thrombopoietin mimetics for systemic lupus erythematosus with antiphospholipid antibodies should be discussed separately (2018) (2)
- Inverse correlation between serum high‐molecular‐weight adiponectin and proinsulin level in a Japanese population: The Dynamics of Lifestyle and Neighborhood Community on Health Study (2020) (2)
- Antiresorptive agents-related osteonecrosis of the jaw (ARONJ) in rheumatoid arthritis (2020) (2)
- MO218: Anca-Associated Vasculitis After SARS-COV-2 Vaccination in a Patient With HLA-DRB1*09: 01 ALLELE: A Case Report and Literature Review (2022) (2)
- Potential therapeutics for antiphospholipid antibody associated thrombocytopenia: A systematic review and meta-analysis (2020) (2)
- Cytokine and chemokine multiplex analysis-based exploration for potential treatment and prognostic prediction in large-vessel vasculitis: A preliminary observational study (2022) (2)
- Posterior scleritis with anti-neutrophil cytoplasmic antibody-associated vasculitis utilizing rituximab therapy to maintain remission: A case report (2022) (2)
- The Efficacy and Safety of Anifrolumab in Japanese Patients With Systemic Lupus Erythematosus: TULIP-2 Subanalysis. (2022) (2)
- Rheumatology practice in Japan: challenges and opportunities (2019) (2)
- Severe infection including disseminated herpes zoster triggered by subclinical Cushing’s disease: a case report (2021) (2)
- Impact of incretin-related agents on endothelial cell function (2017) (2)
- Anti-TIF1γ antibody predicted malignancy of thymic tumor with dermatomyositis as an “autoimmune tumor marker” (2018) (2)
- Do DPP-4 inhibitors improve endothelial cell function? (2017) (2)
- Impact of renal transplantation on glucose tolerance in Japanese recipients with impaired glucose tolerance (2017) (2)
- Aberrant functional connectivity between anterior cingulate cortex and left insula in association with therapeutic response to biologics in inflammatory arthritis. (2022) (2)
- Potential Importance of a Histopathological Analysis in Thyroidal Diseases with High Serum IgG4 Levels (2017) (2)
- Dipeptidyl peptidase‐4 inhibitor might exacerbate Graves’ disease: A multicenter observational case–control study (2021) (2)
- Effects of switching from a dipeptidyl peptidase-4 inhibitor to luseogliflozin on nocturnal blood pressure in patients with type 2 diabetes: protocol for a multicentre, prospective, randomised, open-label, blinded endpoint parallel-group comparison study (2020) (2)
- The risk factors for hepatic steatosis in patients with primary aldosteronism. (2020) (2)
- Ribophorin II is involved in the tissue factor expression mediated by phosphatidylserine-dependent antiprothrombin antibody on monocytes. (2016) (2)
- Improvement of skin temperature of fingers by beraprost sodium in patients with Raynaud's phenomenon (1993) (2)
- A case of catastrophic antiphospholipid antibody syndrome complicated with systemic lupus erythematosus, double positive for anti-cardiolipin/β2 glycoprotein I and anti-phosphatidylserine/prothrombin autoantibodies (2012) (2)
- Safety and Effectiveness of Baricitinib for Rheumatoid Arthritis in Japanese Clinical Practice: 24-Week Results of All-Case Post-Marketing Surveillance. (2022) (2)
- Selection of treatment regimens based on shared decision-making in patients with rheumatoid arthritis on remission in the FREE-J study (2022) (2)
- Detection of Autoreactive Type II NKT Cells: A Pilot Study of Comparison Between Healthy Individuals and Patients with Vasculitis (2018) (2)
- Disseminated Cryptococcosis with Bronchiolitis and Cellulitis. (2019) (2)
- Impact of endogenous insulin secretion on the improvement of glucose variability in Japanese patients with type 2 diabetes treated with canagliflozin plus teneligliptin (2020) (2)
- [Autophagy in autoimmune disease]. (2014) (2)
- Efficacy and safety of filgotinib in combination with methotrexate in Japanese patients with active rheumatoid arthritis who have an inadequate response to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 1). (2021) (2)
- A Caution in the use of the NAFIC Scoring System as a Diagnostic Screening Tool for Nonalcoholic Steatohepatitis (2014) (2)
- 1573-P: Inverse Association between Serum High-Molecular-Weight Adiponectin Level and Proinsulin Level in a General Japanese Population: DOSANCO Health Study (2020) (2)
- Silent pituitary adenoma and metabolic disorders: obesity, abnormal glucose tolerance, hypertension and dyslipidemia. (2020) (2)
- Improvement in the proinsulin/C-peptide ratio during treatment with ipragliflozin in Japanese patients with type 2 diabetes mellitus (2018) (2)
- Pathophysiology of the antiphospholipid syndrome: roles of anticardiolipin antibodies in thrombosis and fibrinolysis (2006) (2)
- Impact of low-starch high-fiber pasta on postprandial blood glucose. (2021) (2)
- Efficacy and safety of filgotinib alone and in combination with methotrexate in Japanese patients with active rheumatoid arthritis and limited or no prior exposure to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 3). (2021) (2)
- Disseminated subcutaneous nodules and destructive polyarthritis (2019) (2)
- Remission of Nephrotic Syndrome After Therapy for Chronic Hepatitis C Virus Infection in a Patient With Systemic Lupus Erythematosus (2018) (2)
- Effects of Palmaria palmata on lipid metabolism and glycemic control in participants with hypercholesterolemia in a randomized double‐blind placebo‐controlled trial (2020) (2)
- Autoantibodies Against High Density Lipoprotein-Associated Proteins Are Related to Elevated Oxidized Low Density Lipoprotein Levels in Antiphospholipid Syndrome (2016) (2)
- Takayasu Arteritis with Varied-size Vessel Involvement (2017) (2)
- A randomised, double-blind, placebo-controlled phase III trial on the efficacy and safety of tocilizumab in patients with familial Mediterranean fever. (2022) (1)
- 2. Systemic Lupus Erythematosus (2010) (1)
- TRAIL-mediated Cytotoxicity: Impacts of sTRAIL and vTRAIL Microvesicles (2006) (1)
- Cyclophilin D regulates NETosis and inflammation in myeloperoxidase-antineutrophil cytoplasmic antibody-associated vasculitis. (2022) (1)
- Luseogliflozin preserves the pancreatic beta-cell mass and function in db/db mice by improving mitochondrial function (2022) (1)
- Prediction of the intolerance or non-responder to Janus kinase inhibitors in patients with rheumatoid arthritis: a preliminary retrospective study with integrative cluster analysis (2021) (1)
- 1993-P: Impact of Laparoscopic Sleeve Gastrectomy on Glycemic Control in Japanese Patients with Obesity and Type 2 Diabetes (2020) (1)
- Clinical and laboratory characteristics of Brazilian versus non-Brazilian primary antiphospholipid syndrome patients in AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) clinical database and repository (2021) (1)
- SAT0131 Continuation/discontinuation of methotrexate and clinical response to etanercept determine the radiographic progression/repair in patients with rheumatoid arthritis: A subanalysis of 52-week results from the JESMR study (2013) (1)
- [The pathogenesis, diagnosis and treatment of antiphospholipid syndrome]. (2014) (1)
- Trigeminal sensory neuropathy in primary Sjoegren's syndrome: case reports and review of the literature. (1992) (1)
- Effects of obesity on CC16 and their potential role in overweight/obese asthma (2022) (1)
- Pixel-by-Pixel Arterial Spin Labeling Blood Flow Pattern Variation Analysis for Discrimination of Rheumatoid Synovitis: A Pilot Study (2016) (1)
- THU0043 AAA-ATPASE P97 Regulates Apoptotic and Autophagy-Associated Cell Death in Arthritis (2015) (1)
- Has lupus anticoagulant testing had its day? (2019) (1)
- Predominant tubulointerstitial nephritis in a patient with systemic lupus erythematosus with an emphasis on CT and MR imaging findings (2009) (1)
- Patients with Systemic Lupus Erythematosus Nucleotide-Releasing Protein 1 in a Subset of Defective Expression of Ras Guanyl (2007) (1)
- Factors associated with successful discontinuation of certolizumab pegol in early rheumatoid arthritis (2020) (1)
- Aberrant splicing of the hRasGRP 4 transcript and decreased levels of this signaling protein in the peripheral blood mononuclear cells in a subset of patients with rheumatoid arthritis (2011) (1)
- The REAL database reveals no significant risk of serious infection during treatment with a methotrexate dose of more than 8 mg/week in patients with rheumatoid arthritis (2011) (1)
- Acute aortic thrombosis related to antiphospholipid antibodies (2017) (1)
- Usefulness of tissue inhibitor of metalloproteinase 1 as a predictor of sustained remission in patients with antineutrophil cytoplasmic antibody-associated vasculitis (2020) (1)
- Cost-Effectiveness Analysis of Etanercept 25 mg Maintenance Therapy After Treatment with Etanercept 50 mg for Moderate Rheumatoid Arthritis in the PRESERVE Trial in Japan (2022) (1)
- Bone mineral density in rheumatoid arthritis by dual energy X-ray absorptiometry (1991) (1)
- Optineurin in Synovial Fibroblasts Plays a Protective Role against Joint Destructions in Rheumatoid Arthritis. (2020) (1)
- Disease and Risk Measurement Criteria in Antiphospholipid Syndrome (2017) (1)
- Antiphospholipid Syndrome Nephropathy Related Disease Diagnosed by Assessing Phosphatidylserine-dependent Antiprothrombin Antibodies (2022) (1)
- Development of ANCA-associated vasculitis followed by SARS-CoV-2 vaccination in a patient with HLA-DRB1*09: 01 allele. (2023) (1)
- [Impaired expression of Act1mRNA in B cells of patients with Sjögren's syndrome]. (2012) (1)
- Supplementary Material for: Circulating Neutrophil Extracellular Trap Levels in Well-Controlled Type 2 Diabetes and Pathway Involved in Their Formation Induced by High-Dose Glucose (2016) (1)
- Pathogenic neuropsychiatric effect of stress-induced microglial interleukin 12/23 axis in systemic lupus erythematosus (2022) (1)
- Abatacept Ameliorates Both Glandular and Extraglandular Involvements in Patients With Sjögren's Syndrome Associated with Rheumatoid Arthritis: Findings from an Open-Label, Multicenter, 1-Year, Prospective Study: the ROSE (Rheumatoid Arthritis with Orencia Trial Toward Sjögren's Syndrome Endocrinopat (2022) (1)
- [Clinical significance of antiphospholipid antibody analysis in diagnosis of collagen diseases]. (2007) (1)
- Comment on “Elevation of Serum Carcinoembryonic Antigen Concentration Caused by Everolimus-Induced Lung Injury: A Case Report” (2018) (1)
- Intrafamilial phenotypic distinction of hypophosphatasia with identical tissue nonspecific alkaline phosphatase gene mutation: a family report (2020) (1)
- AAA-ATPase p 97 suppresses apoptotic and autophagy-associated cell death in rheumatoid arthritis synovial fibroblasts (2017) (1)
- Do the benefits of sodium-glucose cotransporter 2 inhibitors exceed the risks in patients with type 1 diabetes? (2021) (1)
- Clinical practice guidelines for the diagnosis and management of patients with acquired hemophilia A approved by The Japanese Society on Thrombosis and Hemostasis (2011) (1)
- Laboratory Markers With Clinical Significance in the Antiphospholipid Syndrome (2017) (1)
- [The antiphospholipid syndrome]. (2013) (1)
- Novel mutation in the ALPL gene with a dominant negative effect in a Japanese family (2021) (1)
- Disease activity at conception predicts lupus flare up to two years after birth: A multicentre long term follow-up study. (2022) (1)
- Efficient detection of pulmonary arterial hypertension using serum haptoglobin level and cardiac MRI in patients with connective tissue diseases: a pilot study. (2018) (1)
- The data of change in macrophage gene expression which induced by perilipin 1 overexpression (2018) (1)
- Factors associated with an inadequate hypoglycemia in the insulin tolerance test in Japanese patients with suspected or proven hypopituitarism. (2017) (1)
- Inhibitor of NF‐κB Kinase Subunit ε Contributes to Neuropsychiatric Manifestations in Lupus‐Prone Mice Through Microglial Activation (2022) (1)
- Diagnostic Value of Vessel Wall Imaging to Determine the Timing of Extracranial-Intracranial Bypass for Moyamoya Syndrome Associated with Active Sjögren's Syndrome: A Case Report. (2022) (1)
- 3. Antiphospholipid Antibody (2007) (1)
- Class 3 phosphoinositide 3‐kinase promotes hepatic glucocorticoid receptor stability and transcriptional activity (2022) (1)
- Letter to the Editor Regarding Efficacy of IDegLira Versus IDegAsp Therapy in Patients with Type 2 Diabetes: A Randomized Crossover Study by isCGM (2022) (1)
- [The association of the disease activity of rheumatoid factor positive vasculitis and the level of rheumatoid factor]. (1995) (1)
- [Clinical significance of antiphospholipid antibody measured by EliA anticardiolipin antibodies and anti-β2Glycoprotein I antibodies in antiphospholipid syndrome]. (2014) (1)
- [Treatment of rheumatic diseases: current status and future prospective. Topics: II. Immunosuppressant/antirheumatic drugs: 9. Mycophenolate mofetil]. (2011) (1)
- Anti-Ganglionic Nicotinic Acetylcholine Receptor Α3 Subunit Antibody as a Potential Biomarker Associated With Lupus Enteritis. (2022) (1)
- 8. Recent Strategy to Treat Patients with Rheumatoid Arthritis (2017) (1)
- Transcriptional dynamics of granulocytes in direct response to incubation with SARS‐CoV‐2 (2022) (1)
- Brain MRI abnormalities defined as risks for poor prognosis in lupus patients with acute confusional state: Are they antibody mediated? (2017) (1)
- Integrated Safety Analysis of Filgotinib Treatment for Rheumatoid Arthritis in Patients from Japan Over a Median of 1.5 Years. (2022) (1)
- A Nationwide Questionnaire Survey on the Prevalence of Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis in Japan. (2021) (1)
- Lipid Droplet Protein PLIN1 Regulates Inflammatory Polarity in Human Macrophages and is Involved in Atherosclerotic Plaque Development by Promoting Stable Lipid Storage (2022) (1)
- The Effect of Everolimus on Refractory Hypoglycemia in a Patient with Inoperable Metastatic Insulinoma Evaluated by Continuous Glucose Monitoring (2018) (1)
- [Biomarker of bone and cartilage destruction in rheumatoid arthritis]. (2015) (1)
- Protein S, C4b-binding protein (C4BP) and beta 2-glycoprotein I (??2-GPI) binding interaction: Inhibition by human monoclonal anticardiolipin antibody (Mo-aCL) (1995) (1)
- Effects of switching from a dipeptidyl peptidase-4 inhibitor to oral semaglutide on glucose metabolism in patients with type 2 diabetes: protocol for a multicentre, prospective, randomised, open-label, parallel-group comparison study (the SWITCH-SEMA 2 study) (2022) (1)
- SAT-413 Does Dipeptidyl Peptidase-4 Inhibitor Exacerbate Graves’ Disease? (2020) (1)
- Correlation between serum proinsulin levels and fatty liver: The Dynamics of Lifestyle and Neighborhood Community on Health Study Health Study (2020) (1)
- 7-LB: Lowering of Blood Pressure and Pulse Rate by Switching from DPP-4 Inhibitor to Luseogliflozin in Patients with Type 2 Diabetes and Hypertension: A Multicenter, Prospective, Randomized, Open-Label, Parallel-Group Comparison Trial (2021) (0)
- Efficacy and safety of filgotinib in Japanese patients with refractory rheumatoid arthritis: Subgroup analyses of a global phase 3 study (FINCH 2). (2021) (0)
- Beneficial effects of nintedanib on cardiomyopathy in patients with systemic sclerosis: a pilot study. (2022) (0)
- IDF21-0056 Effects of pemafibrate on lipid metabolism in patients with hypertriglyceridemia complicated with type 2 diabetes (2022) (0)
- Antiphospholipid Syndrome and Thrombosis (2005) (0)
- [Retroperitoneal fibrosis presenting with multiple fibrosis, starting with left fingers contracture]. (1989) (0)
- SAT-002 Measurement of Visceral Fat Using Computed Tomography in Two Subtypes of Primary Aldosteronism (2019) (0)
- Genome-wide Association Study of Idiopathic Osteonecrosis of the Femoral Head (2017) (0)
- 686-P: Unstable Glucose Variability in Type 2 Diabetes Patients with Small Abdominal Visceral Fat Area and Impaired Endogenous Insulin Secretion (2022) (0)
- Acknowledgement to referees (2020) (0)
- Effectiveness of a Medical English Course on Communication Abilities of Graduate Medical Students (2017) (0)
- Prediction of outcome of treatment by gene expression profiling of peripheral blood in patients with microscopic polyangiitis (2013) (0)
- [Management of antiphospholipid syndrome]. (2009) (0)
- Correlation between serum proinsulin levels and fatty liver: the DOSANCO Health Study. (2020) (0)
- 76 Rasgrp4 expression in rheumatoid synovium plays a critical role via ras- mapk pathway (2017) (0)
- Kiyohara 2014 ACR (2015) (0)
- P0340CYPD DEFICIENCY AMELIORATES AUTOIMMUNE VASCULITIS IN MOUSE MODEL VIA THE INHIBITION OF PROGRAMMED NECROSIS (2020) (0)
- [Antiphospholipid antibodies and thrombosis]. (2001) (0)
- P217 Efficacy and safety of filgotinib for patients with RA naïve to MTX therapy: FINCH3 primary outcome results (2020) (0)
- SaO001THE EFFECT OF L-TYPE AMINO ACID TRANSPORTER 1 IN THE CYST FORMATION OF MODEL MICE FOR POLYCYSTIC KIDNEY DISEASE (2019) (0)
- Intractable complication of collagen disease. Advances in diagnosis and treatment. IV. Blood lesion. 1. Antiphospholipid syndrome. (2001) (0)
- Glycogen synthase kinase 3β/CCR6‐positive bone marrow cells correlate with disease activity in multicentric Castleman disease‐TAFRO (2021) (0)
- Fluvastatin prevents the development of arthritis in env-pX rats via up- regulation of Rho GTPase-activating protein 12. (2020) (0)
- Long-term safety and effectiveness of abatacept in Japanese patients with rheumatoid arthritis: 3-year follow-up of a postmarketing surveillance. (2021) (0)
- Risk modification by CYP1A1 and GSTM1 polymorphisms in the association of cigarettesmokingandsystemiclupuserythematosusinaJapanesepopulation (2012) (0)
- Clinical and Laboratory Characteristics of Persistently Antiphospholipid Antibody Positive Patients: Retrospective Results from Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository (""Registry"") (2018) (0)
- A case of systemic lupus erythematosus with pure red cell aplasia responded to steroid pulse therapy (1991) (0)
- Axial Spondyloarthritis in Diffuse Idiopathic Skeletal Hyperostosis (2022) (0)
- Recent Advances in Systemic Lupus Erythematosus (2022) (0)
- Inverse association between glucose variability and body fat in type 2 diabetes with impaired endogenous insulin secretion using continuous glucose monitoring: a prospective observational study. (2023) (0)
- Safety of belimumab in adult patients with systemic lupus erythematosus: Results of a large integrated analysis of controlled clinical trial data (2022) (0)
- OP0191 Prophylaxis for the Prevention of Obstetric Complications in Asymptomatic Women with Antiphospholipid Antibodies (2015) (0)
- [Recent progress of diagnosis and treatment for immune-mediated hematological diseases. Topics: II. Differential diagnosis; 1. Idiopathic thrombocytopenic purpura and antiphospholipid syndrome]. (2014) (0)
- [EFFECT OF CARDIAC INSUFFICIENCY OF VARIOUS ORGANS]. (1964) (0)
- PO027 A COMPARISON OF THE EFFECTS OF THE GLP-1 ANALOGUE LIRAGLUTIDE AND INSULIN GLARGINE ON METABOLIC PARAMETERS AND ENDOTHELIAL FUNCTION (2014) (0)
- Dr. Kato and Dr. Atsumi reply (2012) (0)
- FRI0295 High risk of idiopathic osteonecrosis in sle patients with high antiphospholipid score and hypertriglyceridemia (2017) (0)
- RENAL DEVELOPMENT AND CYSTIC DISEASES MO019 MATERNAL UNDERNUTRITION AMELIORATES CYST GROWTH IN ADPKD MODEL MICE (2021) (0)
- Household income and the risk of incident hypertension in employees at multiple workplaces in Japan: J-HOPE (2020) (0)
- Author response for "Favorable effect of the SGLT2 inhibitor canagliflozin plus the DPP‐4 inhibitor teneligliptin in combination on glycemic fluctuation: An open‐label, prospective, randomized, parallel‐group comparison trial (the CALMER study)" (2019) (0)
- ODP279 A Case of Nephrogenic Diabetes Insipidus Diagnosed at an Advanced Age in a Female Patient with an AVPR2 Gene Mutation and Skewed×Inactivation (2022) (0)
- The assessment of left heart disease in patients with systemic sclerosis and pulmonary hypertension. (2021) (0)
- [NETs in pathogenesis of vasculitis]. (2014) (0)
- Active synovitis in the presence of osteitis predicts residual synovitis in patients with rheumatoid arthritis with a clinical response to treatment (2016) (0)
- 1855-P: Effects of Dapagliflozin and/or Insulin Glargine on Hepatic Steatosis in db/db Mice (2019) (0)
- 1465-P: Metabolic Remodeling in Pancreatic Beta Cells in Japanese Patients with Type 2 Diabetes (2022) (0)
- Task Force Report on “Non-criteria” Antiphospholipid Antibody Tests (2012) (0)
- Chemoprophylaxis against Pneumocystis jirovecii pneumonia in Japanese patients with ANCA-associated vasculitis: an observational study. (2022) (0)
- Improvement of glycaemic control and treatment satisfaction by switching from liraglutide or dulaglutide to subcutaneous semaglutide in patients with type 2 diabetes: A multicentre, prospective, randomized, open‐label, parallel‐group comparison study (SWITCH‐SEMA 1 study) (2023) (0)
- Direct visualization of glucagon‐like peptide‐1 secretion by fluorescent fusion proteins (2022) (0)
- Protective effect of perilipin1 overexpression in macrophages on progression of atherosclerosis. (2017) (0)
- Comment on: The efficacy of tacrolimus in patients with interstitial lung diseases complicated with polymyositis or dermatomyositis: reply. (2015) (0)
- 1462-P: Effect of Energy Restriction on the Intracellular Metabolism of Rodent Pancreatic ß-Cells In Vitro and Obese Mice (2022) (0)
- “Endotheliology” in Antiphospholipid Antibodies (2001) (0)
- Lymphocytic panhypophysitis and anti-rabphilin-3A antibody with pulmonary sarcoidosis (2022) (0)
- RasGRP 4 is Aberrantly Expressed in the Fibroblast-like Synoviocytes of Patients with Rheumatoid Arthritis and Controls their Proliferation (2014) (0)
- [111th Scientific Meeting of the Japanese Society of Internal Medicine: Educationnal Lecture: 2. Systemic lupus erythematosus: Diagnosis and treatment]. (2014) (0)
- Test procedures for lupus anticoagulant and reagent (2002) (0)
- Effect of the sodium–glucose cotransporter 2 inhibitor luseogliflozin on pancreatic beta cell mass in db/db mice of different ages (2018) (0)
- Low disease activity of microscopic polyangiitis in patients with anti-myosin light chain 6 antibody that disrupts actin rearrangement necessary for neutrophil extracellular trap formation (2022) (0)
- SP004LONG-TERM TREATMENT OF TOLVAPTAN FOR AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE: A SINGLE CENTRE RETROSPECTIVE COHORT STUDY (2019) (0)
- P15 THE EFFECT OF PEPTIGYLARGININE DEIMINASE 4 INHIBITOR ON MPO-ANCA PRODUCTION IN MOUSE MODEL (2016) (0)
- The efficacy of ^|^ldquo;Antiphospholipid Score^|^rdquo; (2012) (0)
- SAT-282 Hypothalamic Pituitary Adrenal Axis Hyperactivity in Db/db Mice (2020) (0)
- CYSTIC DISEASE AND CILIOPATHIES (2014) (0)
- Kasabach–Merritt phenomenon with concurrent appearance of antiphospholipid antibodies in a patient with giant liver haemangioma (2018) (0)
- A Case of Transient Hypoprothrombinemia Associated with Lupus Anticoagulant with Phosphatidylserine-Dependent Anti-Prothrombin Antibody (2009) (0)
- [Antiphospholipid syndrome: new criteria and management of the patients]. (2003) (0)
- Vascular endothelial growth factor (VEGF)-A and VEGF-A165b are associated with time to remission of granulomatosis with polyangiitis in a nationwide Japanese prospective cohort study (2020) (0)
- Urethral injury related to peri‐urethral abscess as a complication of self‐catheterization in an older patient with type 2 diabetes (2022) (0)
- Instructions for use Title Pathogenesis of antiphospholipid antibodies : Impairment of fibrinolysis and monocyte activation viathe p 38 mitogen-activated protein kinase pathway (2017) (0)
- Dynamics of corticocortical brain functional connectivity relevant to therapeutic response to biologics in inflammatory arthritis (2022) (0)
- PO309 LIMITATION OF THE DIAGNOSTIC SCREENING TOOL FOR NONALCOHOLIC STEATOHEPATITIS IN NON-OBESE JAPANESE PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE (2014) (0)
- Novel development of collagen disease rheumatism medical care. III. Complication. 3. Collagen disease and thrombosis. (2005) (0)
- A case of essential crystallizing cryoglobulinemia (1994) (0)
- Connective tissue disease associated TMA (2014) (0)
- Predicting the response to pulmonary vasodilator therapy in systemic sclerosis with pulmonary hypertension by using quantitative chest CT. (2022) (0)
- [Takayasu disease and fibrinolysis]. (1967) (0)
- False hypercortisolemia due to abnormal albumin-cortisol binding in a patient with familial dysalbuminemic hyperthyroxinemia. (2021) (0)
- [Immunological and serological tests for diagnosis of rheumatoid arthritis: anti-agalactosyl IgG antibody]. (2005) (0)
- [The function and the significance of full-automated tests for detecting antiphospholipid antibodies]. (2015) (0)
- FP061RECOMBINANT THROMBOMODULIN AMELIORATES VASCULITIS VIA THE INHIBITION OF NEUTROPHIL EXTRACELLULAR TRAPS (2019) (0)
- Risk factors for hospitalization or mortality for COVID-19 in patients with rheumatic diseases: Results of a nation-wide JCR COVID-19 registry in Japan. (2022) (0)
- Kobe University Repository : Kernel Tit le Ant i-beta 2 glycoprotein-I ant ibody increases the risk of pregnancy-induced hypertension : a case-controlled study (2017) (0)
- FRI0099 PREDICTIVE FACTORS FOR REMISSION ACHIEVEMENT BY TOCILIZUMAB MONOTHERAPY IN PATIENTS WITH RHEUMATOID ARTHRITIS AFTER INADEQUATE RESPONSE TO METHOTREXATE: A POST HOC ANALYSIS OF THE SURPRISE STUDY (2019) (0)
- 2101-P: Adipose Tissue Insulin Resistance in Overweight and Lean Patients with Impaired Glucose Tolerance or Type 2 Diabetes (2019) (0)
- ODP332 Maternal Central Diabetes Insipidus Immediately after Delivery, Owing to Vasospasm of the Internal Carotid Artery (2022) (0)
- Effects of pemafibrate on lipid metabolism in patients with type 2 diabetes and hypertriglyceridemia: a multi-center prospective observational study, the PARM-T2D study. (2022) (0)
- Reversible Diffuse Bronchial Wall Thickening (2022) (0)
- [The significance of antiphospholipid antibodies tests]. (2013) (0)
- Homonymous hemianopsia and headache with mass-like lesion. (2023) (0)
- SP028SMALL TOTAL KIDNEY VOLUME IS COLLERATED WITH EFFECT OF TOLVAPTAN IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE PATIENTS (2016) (0)
- ODP037 Effects of DHCR24 Inhibitor on Excessive Adrenal Steroidogenesis in db/db mouse (2022) (0)
- The participations of the physicians on the diagnosis and treatments of antiphospholipid related pregnancy morbidities in Japan: from the result of nationwide survey. (2015) (0)
- Regulation of NETosis and Inflammation by Cyclophilin D in Myeloperoxidase‐Positive Antineutrophil Cytoplasmic Antibody–Associated Vasculitis (2023) (0)
- Long-Term Safety and Efficacy of Filgotinib Treatment for Rheumatoid Arthritis in Japanese Patients Naïve to MTX Treatment (FINCH 3). (2022) (0)
- 018. ANTI-NEUTROPHIL EXTRACELLULAR TRAP ANTIBODY IN PATIENTS WITH MICROSCOPIC POLYANGIITIS (2019) (0)
- Salivary gland LAMP3 mRNA expression is a possible predictive marker in the response to hydroxychloroquine in Sjögren’s disease (2023) (0)
- FRI0350 The Scaffold Protein P62 Regulates Cell Death, Autophagy and the Ubiquitin-Proteasome System in Rheumatoid Arthritis Synovial Fibroblasts (2014) (0)
- [Clinical significance of antiphospholipid antibody in diagnosis of collagen diseases]. (2007) (0)
- 2268-PUB: Relationship between Serum Free Fatty Acid and Proinsulin Concentrations (2020) (0)
- Convolutional neural network for classification of two-dimensional array images generated from clinical information may support diagnosis of rheumatoid arthritis (2020) (0)
- MON-492 A Case of Gitelman’s Syndrome with Hyperphosphatemia That Responded Effectively to Single Oral Administration of Magnesium Oxide (2019) (0)
- SAT-177 Relationship Between Visceral Fat and the Position of Adrenal Glands in Cranial-Caudal Direction in Patients with Primary Aldosteronism (2020) (0)
- MO244CD47 BLOCKADE AMELIORATES AUTOIMMUNE VASCULITIS VIA THE EFFEROCYTOSIS OF NEUTROPHIL EXTRACELLULAR TRAPS* (2021) (0)
- Antiphospholipid syndrome and the complement activation (2016) (0)
- Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An APS ACTION Study. (2023) (0)
- Comment on: Beneficial effects of nintedanib on cardiomyopathy in patients with systemic sclerosis: a pilot study: Reply. (2023) (0)
- FP048DIETARY PROTEIN LOADING MODULATES DISEASE PROGRESSION IN AN ORTHOLOGOUS MOUSE MODEL OF ADPKD (2015) (0)
- Clinical significance of lupus anticoagulant and genome-wide association study in obstetric antiphospholipid syndrome (2016) (0)
- FO038EFFECTS OF RECOMBINANT THROMBOMODULIN ON EXPERIMENTAL AUTOIMMUNE VASCULITIS VIA THE INHIBITION OF NEUTROPHIL EXTRACELLULAR TRAPS (2018) (0)
- Moyamoya Disease Associated with a Deficiency of Complement Component 6. (2022) (0)
- PO139 DIFFERENT EFFECT OF SHORT-TERM AND LONG-TERM HIGH-FAT DIET FEEDING ON PANCREATIC BETA CELL PROLIFERATION (2014) (0)
- SP016EFFICACY AND SAFETY OF TOLVAPTAN ON ADPKD PATIENTS IN LATE-STAGE CKD (2016) (0)
- 780-P: Improved Mitochondrial Function by Luseogliflozin Prevents Pancreatic Beta-Cell Damage (2021) (0)
- Number Needed to Treat and Cost Per Responder of Janus Kinase Inhibitors Approved for the Treatment of Moderate-to-Severe Rheumatoid Arthritis in Japan. (2022) (0)
- Lupus-induced autoimmune chloride channelopathy like myotonia congenita, successfully treated with immunosuppression. (2021) (0)
- Gitelman's syndrome with hyperphosphatemia, effectively responding to single oral magnesium oxide administration (2019) (0)
- [Programs for Continuing Medical Education 2016: A Session: 8. Recent Strategy to Treat Patients with Rheumatoid Arthritis]. (2017) (0)
- OP0213 MYOFASCIA-DOMINANT: INFLAMMATION DETECTED ON WHOLE BODY MRI PREDICTS RAPIDLY PROGRESSIVE INTERSTITIAL LUNG DISEASE IN PATIENTS WITH DERMATOMYOSITIS (2019) (0)
- AB0293 High Serum Levels of Anti-Cyclic Citrullinated Peptide Antibody and Matrix Metalloproteinase-3 at the Time of Diagnosis of Rheumatoid Arthritis Are Possible Predictors of Future Initiation of Biological Agents (2015) (0)
- The association of food anaphylaxis in antiphospholipid syndrome and thrombosis cannot be considered a coincidence (2011) (0)
- A case of systemic lupus erythematosus developing pneumoperitoneum without perforation of the gastrointestinal tract (1993) (0)
- Favorable Effects of Burosumab on Fibroblast Growth Factor 23-Related Osteomalacia: A Case Report (2021) (0)
- Adult Still's disease presenting with cerebral infarction : Case report (2007) (0)
- Instructions for use Title A Randomized Controlled Trial Comparing the Effects of Sitagliptin and Glimepiride on Endothelial Function andMetabolic (2018) (0)
- Safety and Efficacy of Filgotinib for Japanese Patients with RA and Inadequate Response to MTX: FINCH 1 52-Week Results and FINCH 4 48-Week Results. (2022) (0)
- 120-OR: Hepatic Steatosis Is Inversely Associated with Improvement of Pancreatic Beta-Cell Function after Vertical Sleeve Gastrectomy in Patients with Type 2 Diabetes (2022) (0)
- Screening for IA in patients with ADPKD after transplantation should be considered. SP012 DIAGNOSIS OF RENAL CYST INFECTION IN ADULT POLICYSTIC KIDNEY DISEASE (ADPKD) USING 67-GA CITRATE SPECT/CT: A CASE SERIES (2017) (0)
- SP175Longitudinal outcome of a restrictive therapeutic algorithm in Japanese patients with idiopathic membranous nephropathy (2019) (0)
- [Programs for Continuing Medical Education: A session; 7. Antiphospholipid syndrome: diagnosis and treatment]. (2015) (0)
- SP020EFFECT OF TOLVAPTAN ON A BODY WATER BALANCE IN PATIENTS WITH AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (2016) (0)
- ODP190 Efficacy of Esaxerenone on Hypertensive Patients with Type 2 Diabetes or Those with Impaired Glucose Tolerance (2022) (0)
- SO006 SURVIVAL AFTER ARTERIAL EMBOLIZATION THERAPY IN PATIENTS WITH POLYCYSTIC KIDNEY DISEASE AND LIVER DISEASE (2014) (0)
- Benefit of Filgotinib, a JAK1 Preferential Inhibitor, in Rheumatoid Arthritis Patients with Previous Rapid Radiographic Progression: Post Hoc Analysis of Two Trials (2022) (0)
- Exchange of information in rheumatology between east and west: from Man'yo-shu to the future. (2008) (0)
- Clinical Benefits and Intensity of Immunosuppression Transplantation in Patients with Systemic Sclerosis : Relationship Between Immunological Reconstitution after Autologous Hematopoietic Stem Cell (2009) (0)
- Quantification of hand synovitis in rheumatoid arthritis: Arterial mask subtraction reinforced with mutual information can improve accuracy of pixel‐by‐pixel time–intensity curve shape analysis in dynamic MRI (2018) (0)
- [Case report; A case of familial focal segmental glomerulosclerosis with a mutation in the formin INF2]. (2013) (0)
- AB0448 SAFETY AND EFFICACY OF FILGOTINIB IN JAPANESE PATIENTS ENROLLED IN A GLOBAL PHASE 3 TRIAL OF PATIENTS WITH ACTIVE RHEUMATOID ARTHRITIS AND INADEQUATE RESPONSE OR INTOLERANCE TO BIOLOGIC DMARDS (2019) (0)
- 1424-P: Impact of Laparoscopic Sleeve Gastrectomy on Nonalcoholic Fatty Liver Disease in Obese Patients with Type 2 Diabetes: Prospective Observational Study (2022) (0)
- FRI0048 Mortality and morbidity of rheumatoid arthritis-associated lung disease during a 10-year period: a longitudinal cohort study of 103 japanese patients (2018) (0)
- Systemic lupus erythematosus complicated with meningitis due to Enterococcus faecium: a case report. (1992) (0)
- SP019TRANSCATHETR ARTERIAL EMBOLIZATION WITH EMBOSPHERE FOR SYMPTOMATIC POLYCYSTIC LIVER DISEASE (2017) (0)
- LAMP3 transfer via extracellular particles induces apoptosis in Sjögren’s disease (2023) (0)
- Tumour necrosis factor alpha blockade for non-inflammatory pain: beyond inflammation? (2019) (0)
- 2084-P: Hepatic Fat Accumulation Underlies the Inability of Glucokinase Activator to Achieve a Sustained Hypoglycemic Effect in db/db Mice (2020) (0)
- Progressive cognitive dysfunction with subdural polycystic hygroma and systemic inflammation under immunosuppressive therapy (2023) (0)
- A Randomized, Double-Blind, Placebo-Controlled Phase III Trial On The Efficacy and Safety of Tocilizumab in Patients With Colchicine-Resistant or -Intolerant Familial Mediterranean Fever (2021) (0)
- MON-483 Familial Dysalbuminemic Hyperthyroxinemia with False Hypercortisolemia (2020) (0)
- MP214CLINICOPATHOLOGIC CHARACTERISTICS AND OUTCOMES OF MPGN : A RETROSPECTIVE STUDY OF 34 CASES BASED ON NEW CLASSIFICATION (2017) (0)
- THU0256 Effectiveness of autologous hematopoietic stem cell transplantation for interstitial lung diseases in patients with systemic sclerosis (2013) (0)
- FP453WEEKLY TERIPARATIDE AGENT POTENTIATES BONE MINERAL TURN OVER IN HEMODIALYSIS PATIENTS WITH LOW PARATHYROID HORMONE (PTH) LEVELS: A PROSPECTIVE STUDY (2019) (0)
- NONALCOHOLIC FATTY LIVER DISEASE IN TWO SUBTYPES OF PRIMARY ALDOSTERONISM (2019) (0)
- Neuromedin B Receptor Antagonist Suppresses Pomc Expression in AtT-20 Cells and Human Corticotroph Adenoma Cells (2021) (0)
- AB0513 Treatment Strategy Targeting Structural Remission in Patients with Early Rheumatoid Arthritis: A Multi-Central, Prospective, Comparative Study Targeting Joint Damage to Zero (Zero-J Study) (2015) (0)
- Comparison of administration of single- and triple-course steroid pulse therapy combined with tonsillectomy for immunoglobulin A nephropathy (2021) (0)
- Subcutaneous Panniculitis-like T-cell Lymphoma Lacking Subcutaneous Tumor Mimicking Adult-onset Still's Disease. (2023) (0)
- Soluble Interleukin-2 Receptor Predicts Treatment Outcome in Patients With Autoimmune Tubulointerstitial Nephritis. A Preliminary Study (2022) (0)
- ODP285 A Case of Encephalitis and Adrenal Insufficiency in a Patient With Panhypopituitarism After COVID-19 Vaccination (2022) (0)
- Pathogenesis of antiphospholipid syndrome (2021) (0)
- Quantitative power Doppler signal assessment in the subchondral bone region of the metacarpophalangeal joint is an effective predictor of radiographic progression in the hand of rheumatoid arthritis: a pilot study (2019) (0)
- Antiphospholipid syndrome and anti-prothrombin/HLA-DR antibody (2016) (0)
- [Anti-phospholipid antibody syndrome]. (2001) (0)
- [Discussion meeting on rheumatoid arthritis: progress in diagnosis and treatment]. (2012) (0)
- MO019MATERNAL UNDERNUTRITION AMELIORATES CYST GROWTH IN ADPKD MODEL MICE* (2021) (0)
- MON-465 Novel Thyroid Hormone β Mutation L266s Causes Atrial Fibrillation & Cerebral Infarction (2020) (0)
- IDF21-0079 The agreement between measured HbA1c and optimized target HbA1c based on the DASC-8 in older patients with diabetes (2022) (0)
- FP125A ROLE OF SOLUBLE INTERLEUKIN-2 RECEPTOR LEVELS IN THE PREDICTION OF STEROID RESPONSE IN PATIENTS WITH TUBULOINTERSTITIAL NEPHRITIS (2019) (0)
- Reply. (2019) (0)
- 1145-P: SGLT2 Inhibitors Improve Day-to-Day Glucose Variability in Patients with Type 1 Diabetes (2020) (0)
- The association between SLC16A11 haplotype and lipid metabolism in Japanese patients with type 2 diabetes. (2020) (0)
- 116-OR: Changes in Glucose Tolerance and Related Factors after Renal Transplantation in Recipients with Impaired Glucose Tolerance (2022) (0)
- The management of women of child-bearing age with rheumatoid arthritis: an expert report. (2023) (0)
- THU0006 Trans-ethnic meta-analysis of genome-wide association studies identifies GSDMA and PRDM1 as susceptibility genes to systemic sclerosis (2017) (0)
- Review Sonographic synovial vascularity of synovitis in rheumatoid arthritis RHEUMATOLOGY (2014) (0)
- ABDOMINAL AORTIC CALCIFICATION IN ALDOSTERONE PRODUCING ADENOMA AND IDIOPATHIC HYPERALDOSTERONISM (2021) (0)
- Correction to: Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION): 10-Year Update (2021) (0)
- LAMP3 induces lysosome-dependent cell death by impairing autophagic caspase-8 degradation in Sjögren's salivary glands. (2023) (0)
- Instructions for use Title Aberrant splicing of the hRasGRP 4 transcript and decreased levels of this signaling protein in the peripheral blood mononuclear cells in a subset of patients with rheumatoid arthritis (2017) (0)
- Improvement of the Quality of Life of a Patient with Colon Ulceration of Systemic Lupus Erythematosus by Successful Surgical Treatment: Report of a Case (2012) (0)
- OP0166 THE EFFICACY OF CALCINEURIN INHIBITORS IN PATIENTSWITH ADULT-ONSET STILL’S DISEASE: MULTI-CENTRE HISTORICAL COHORT STUDY (2019) (0)
- 2361-PUB: Enhancement of Flattening Glycemic Fluctuation in Patients with Type 2 Diabetes by SGLT2 Inhibitor Combined with DPP-4 Inhibitor (2019) (0)
- AB0486 Effect of Baseline Disease Duration on Development of Clinical Remission in the RA Patients Receiving Tocilizumab – Data from PMS with Tocilizumab in Biologics-Naïve RA Patients (First Bio) Study (2015) (0)
- An Antiphospholipid Antibody Profile as a Biomarker for Thrombophilia in Systemic Lupus Erythematosus (2023) (0)
- Etiopathology of the Antiphospholipid Syndrome (2008) (0)
- SLE and other connective tissue diseases (human studies) (PP-016) (2010) (0)
- Difference in Hepatic Steatosis and Pancreatic Beta-Cell Mass between Dapagliflozin and Insulin Glargine Treatment at Comparable Levels of Glycemic Control (2018) (0)
- Itaconate ameliorates autoimmunity by modulating T cell imbalance via metabolic and epigenetic reprogramming (2023) (0)
- ODP338 Neuromedin B Receptor Antagonist Suppresses ACTH Secretion and Cell Proliferation in Human and Mouse Corticotroph Adenoma (2022) (0)
- Correction of LAMP3-associated salivary gland hypofunction by aquaporin gene therapy (2022) (0)
- Lupus Erythematosus in a Japanese Population Polymorphisms , and Systemic TNFRSF 1 B and STAT 4 Cigarette Smoking , (2009) (0)
- β2-glycoprotein I complexed with MHC class II molecules are involved in the pathogenesis of antiphospholipid syndrome (2015) (0)
- SP013EFFICACY OF TOLVAPTAN ON AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) PATIENTS IN LATE-STAGE CKD (2017) (0)
- Hypothalamic lesion in a neuropsychiatric lupus patient with narcolepsy. (2023) (0)
- SAT-271 Block and Replace Therapy Successfully Improved Symptoms in Recurrent Cyclic Cushing’s Disease (2020) (0)
- New therapeutic targets for antiphospholipid syndrome (2007) (0)
- Branched chain amino acids in the treatment of polymyositis and dermatomyositis: a phase II/III, multi-center, randomized controlled trial. (2022) (0)
- Intensity of Immunosuppression Transplantation in Patients with Systemic Sclerosis : Clinical Benefits and Immunological Reconstitution after Autologous Hematopoietic Stem Cell (2009) (0)
- A likely unavoidable clinical scenario during treatment for venous thromboembolism complicated with severe immune thrombocytopenia: A case report (2021) (0)
- ODP328 Longitudinal Multidisciplinary Approach for Cabergoline-Resistant Aggressive Prolactinoma Complicated by Multiple Endocrine Neoplasia Type 1 (2022) (0)
- The association between hypoglycemia and glycemic variability in elderly patients with type 2 diabetes: cross-sectional study (2020) (0)
- 2. Systemic Lupus Erythematosus: Diagnosis and Treatment (2014) (0)
- SP027EFFICACY OF TOLVAPTAN ON AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE (ADPKD) PATIENTS IN LATE STAGE CKD (2018) (0)
- Nicked (cid:1) 2 -glycoprotein I: a marker of cerebral infarct and a novel role in the negative feedback pathway of extrinsic fibrinolysis (2004) (0)
- 1497-P: Proinsulin as a Potential Marker of Early Pancreatic Beta-Cell Dysfunction (2019) (0)
- Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository (“Registry”) (2022) (0)
- Predictors of damage accrual in patients with antineutrophil cytoplasmic antibody-associated vasculitis: A nationwide prospective study. (2023) (0)
- Add-on imeglimin versus metformin dose escalation regarding glycemic control in patients with type 2 diabetes treated with a dipeptidyl peptidase-4 inhibitor plus low-dose metformin: study protocol for a multicenter, prospective, randomized, open-label, parallel-group comparison study (MEGMI study) (2022) (0)
- 272 Clinical significance of anti-dna/nr2 antibodies in de novo npsle and post-steroid npsle (2017) (0)
- [Study on usefulness of different APTT test kit in variable coagulopathy]. (2008) (0)
- [Antiphospholipid syndrome]. (2005) (0)
- [Case of polymyositis associated with aplastic anemia]. (1983) (0)
- The agreement between measured HbA1c and optimized target HbA1c based on the Dementia Assessment Sheet for Community‐based Integrated Care System 8‐items (DASC‐8): A cross‐sectional study of elderly patients with diabetes (2022) (0)
- Acromegaly Cases Exhibiting Increased Growth Hormone Levels during Oral Glucose Loading with Preadministration of Dipeptidyl Peptidase-4 Inhibitor (2021) (0)
- SAT0612 The efficacy of calcineurin inhibitors in patients with adult-onset still’s disease: single-centre historical cohort study (2018) (0)
- FP066BODY COMPOSITION MEASUREMENTS USING BIOIMPEDANCE ANALYSIS IN AUTOSOMAL DOMINANT POLYCYSTIC KIDNEY DISEASE PATIENTS TREATED WITH TOLVAPTAN (2015) (0)
- [Neurological Manifestations in Antiphospholipid Syndrome]. (2021) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Tatsuya Atsumi?
Tatsuya Atsumi is affiliated with the following schools:
